Stem cell rescue for CAR-T patients with lingering blood problems
NCT ID NCT07212335
Summary
This early-stage study is testing whether stem cells from donated umbilical cords can safely help patients recover their blood cell counts after receiving CAR-T therapy for certain blood cancers. It will enroll up to 24 adults with leukemia, lymphoma, or myeloma who still have very low blood counts three weeks after their CAR-T treatment. The main goal is to see if the stem cell infusions are safe and if they help the body rebuild its blood cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNE EFFECTOR CELL ASSOCIATED HEMATOTOXICITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chinese Academy of Medical Sciences Hospital of Hematology (Chinese Academy of Medical Sciences Institute of Hematology)
RECRUITINGTianjin, 300020, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.